Can psychedelics cause lasting harm? Psychosis, flashbacks and HPPD explained

Psychedelics are described as physiologically safe and rarely addictive, yet doctors also describe two serious problems that affect a minority of people: psychosis that outlasts the drug, and visual changes that do not fade.

Yes, in a minority of cases. Some studies describe psychedelics as physiologically safe and rarely addictive. But two lasting problems are described in the medical literature: that continues after the drug's effects, and persistent visual changes called HPPD. This lesson describes what is reported; it is not a guide to use.

The first is hallucinogen-induced psychotic disorder (HIPD), a form of substance-induced . Its symptoms are paranoia, , hallucinations, disorganised thinking or behaviour, or insomnia that continue after the drug's effects have gone. People with a personal or family history of mental illness are at the highest risk. Reported rates are 0.6% in randomised controlled trials that exclude people with bipolar disorder or schizophrenia, and 3.8% in studies that included people with schizophrenia. A 2019 found that 26% of people diagnosed with HIPD later received a diagnosis of schizophrenia, though a later analysis of psychedelics only found 13%.

The second is hallucinogen persisting perception disorder (HPPD): a non-psychotic disorder with persistent visual changes, most often found among frequent users. Symptoms may include , trails and , and intensified colours. It differs from HIPD in that it involves lasting visual changes only, without paranoia or . Little is known about effective treatments, and the mechanisms are not well understood.

Two different problems

HIPD (psychosis)

  • Paranoia, , hallucinations
  • Disorganised thinking or behaviour, insomnia
  • Continues after the drug's effects

HPPD (visual changes)

  • Persistent visual changes such as and trails
  • No paranoia or
  • Little known about treatment

Researchers also note milder, longer-lasting effects: a 2023 international survey found 14% felt more anxious for an extended period afterwards. This is also why modern trials screen out people at risk of .

Quiz me

0/3

  1. 1.Who is described as being at highest risk of hallucinogen-induced psychosis?
  2. 2.How is HPPD different from hallucinogen-induced psychotic disorder?
  3. 3.What did the 2022 double-blind study of 142 people report?

Recap

Psychedelics rarely lead to addiction, but psychosis and HPPD are real risks for a minority, and the risk is highest in people with a personal or family history of mental illness.

💡 A trick to remember it · Light on the body, heavier on the mind: the risk follows the person's history, not just the drug.

Surprising fact · Reported HIPD rates were 0.6% in trials that excluded people with schizophrenia or bipolar disorder, against 3.8% in studies that included them.

Sources (3)

No source, no claim. Every fact in this lesson (15 claims) cites at least one of these.

  1. [1]Psychedelic drug · Wikipedia
  2. [2]Hallucinogen persisting perception disorder · Wikipedia
  3. [3]Hallucinogen · Wikipedia
More lessons in 🫀 Human body (3) See all human body lessons →

One more light on your map.

Get one lesson like this every day, about the things you love. Free, in two or five minutes.

Get the share card for this lesson ↗